The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen

The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen

Abstract Multiple myeloma (MM) is the second most common hematological malignancy. Previous studies have validated the prognostic significance of the platelet-to-lymphocyte ratio (PLR) in patients with certain solid tumors. However, the relationship between the PLR and prognosis in myeloma patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Quane Zhang, Yifan Wang, Wenting Shi, Yue Chen, Zhengmei He, Liang Yu, Chunling Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Platelet-to-lymphocyte ratio
Multiple myeloma
Prognostic factors
Bortezomib-based chemotherapy
Restricted cubic splines
Online Access:https://doi.org/10.1038/s41598-024-84343-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items